Scott Tarriff, CEO at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 36,856 shares at $50.51 ($1.9M) on 2019-03-01, disclosed to the SEC on 2019-03-04.
Open-market sale of $1.9M EGRX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.51 | 12,000 | $606K | 32.0% |
| 2 | $51.81 | 12,428 | $644K | 34.0% |
| 3 | $51.81 | 12,428 | $644K | 34.0% |
| Total | $51.39 avg | 36,856 | $1.9M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |